Portal Hypertension News

Incidence of new portal vein thrombosis was higher after transarterial chemoembolization for hepatocellular carcinoma compared with microwave or radiofrequency ablation, although researchers reported no clinically significant sequalae.

Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver dysfunction without an increase in major bleeding events, according to data presented at the EASL Congress.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

LONDON — Noninvasive testing may predict clinically significant portal hypertension and other outcomes in patients after hepatitis C virus cure, according to research presented at the International Liver Congress.

Healio Gastroenterology and Hepatology presents the following report on highlights from The Liver Meeting Digital Experience.

Regarding cardiovascular mortality, results published in the Scandinavian Journal of Gastroenterology demonstrated a negative interaction between fatty liver disease and hypertension in nondiabetic men.

The American College of Gastroenterology released a new guideline on disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries, which can lead to acute liver failure, chronic liver disease, noncirrhotic portal hypertension, cirrhosis, and hepatocellular carcinoma.

SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services important for all practitioners involved in the care of patients with liver disease.

CHICAGO — Researchers determined clinical scores that assessed short-term risks for liver disease associated with isolated heart transplantation with the Fontan procedure in pediatric patients, according to a study presented at NASPGHAN 2019.